Dose-Dense Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Node-Positive Breast Cancer

Background. Adding taxanes to anthracycline-based adjuvant chemotherapy has shown significant improvement in node-positive breast cancer patients but the optimal dose schedule has still remained undetermined. Objectives. The feasibility of dose-dense epirubicin in combination with cyclophosphamide (...

Full description

Saved in:
Bibliographic Details
Main Authors: Mirzaei, Hamid Reza, Nasrollahi, Fatemeh, Mohammadi Yeganeh, Ladan, Jafari Naeini, Sepideh, Bikdeli, Pegah, Hajian, Parastoo
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2014
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4172875/
https://ncbi.nlm.nih.gov/pubmed/25276426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/259312
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items